Meyka Pro banner
Scholar Rock Holding Corporation

Scholar Rock Holding Corporation (SRRK) Stock Overview

Explore Scholar Rock Holding Corporation’s financial performance, market position, analyst ratings, and future outlook.

SRRKNASDAQ
HealthcareBiotechnology
$60.04
$1.79(3.07%)
U.S. Market opens in 3h 39m

Scholar Rock Holding Corporation (SRRK)

Meyka AI Score

Z

Key Financials

Market Cap7.2B
P/E Ratio-18.28
EPS (TTM)$-3.45
ROE-1.60%
Fundamental Analysis

AI Price Forecasts

1 Month$54.01
3 Months$47.20
1 Year Target$63.14

SRRK Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Scholar Rock Holding Corporation (NASDAQ: SRRK) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Scholar Rock Holding Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SRRK on the NASDAQ shows an RSI of 70.84, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $63.14 for the NASDAQ listing.

Key metrics behind Scholar Rock Holding Corporation's NASDAQ-traded stock include a P/E ratio of -18.28 and a market capitalization of 7.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of SRRK on the NASDAQ.

Price Performance (NASDAQ: SRRK)

1-Day Change
3.07%
5-Day Change
8.41%
1-Month Change
25.95%
3-Month Change
16.56%
6-Month Change
33.90%
Year-to-Date (YTD) Change
36.30%
1-Year Change
77.74%
3-Year Change
887.50%
5-Year Change
53.44%
All-Time (Max) Change
287.35%

Contact Information

857 259 3860
301 Binney Street, Cambridge, MA, 02142

Company Facts

2,890 Employees
IPO DateMay 25, 2018
CountryUS
Actively Trading

Frequently Asked Questions